Forging the Future of
Precision Pediatric Care

Transforming children’s lives through genomic sequencing

At Rady Children’s Institute for Genomic Medicine (RCIGM), we are pushing the boundaries of science and engineering to speed answers and hope for newborns and children with rare, genetic diseases. By rapidly delivering genomic insights, we empower physicians with the information they need to provide precision care for the youngest and most fragile patients.



Frontiers in Genomic Pediatric Medicine Conference, April 25-27, 2018
8610 Kennel Way ( formerly Discovery Way)
La Jolla, CA 92037
Prepare to Shape the Future: Explore innovations in rapid Whole Genome Sequencing through patient stories, case studies and discussions with leaders in research, industry and healthcare.



Sequencing to Save Lives, Lower Cost of Healthcare
Our economic analysis shows using rapid Whole Genome Sequencing in the NICU to deliver precise diagnosis and guide treatment decreases infant mortality and the cost of hospitalization. Read our latest findings and news.



Speeding answers and hope
The Institute team is committed to expanding delivery of rapid precision medicine to children’s hospitals across the country. Our vision is to increase access to this life-saving technology to all children who need it.


Our Work

From a single blood sample, RCIGM scientists can screen for thousands of rare genetic diseases to rapidly identify the root causes of a child’s condition and facilitate medical decision making.


Our laboratory is licensed and certified to perform clinical grade diagnostic testing via rapid Whole Genome Sequencing. The Institute has engineered a process to compress the time needed to sequence, analyze, interpret and deliver test results in just a few days.


Research Focus Areas

RCIGM was founded to build a research-to-bedside genomic sequencing pipeline, with the goal of making genetic screening fast, easy and routine for diagnosing and delivering precision medicine to acutely ill babies and children.

Neonatal/ Pediatric Intensive Care
Rapid Whole Genome Sequencing is used to decode rare genetic disorders in newborns & children hospitalized in intensive care who are enrolled in one of our multi-center clinical studies.
Precision Neuro-Oncology
Brain tumors are the leading cause of cancer death in children. Our goal is to develop personalized therapy for pediatric brain tumors by seeking more effective & less toxic approaches to treatment.
Precision Neuro-Genomics
Genomic sequencing is used to decipher the medical mysteries behind genetically-caused neurological disorders, with the goal of providing a diagnosis to guide targeted medical treatment.
The genomic technology & bioinformatics team uses process engineering principles to develop & optimize novel information technology platforms & validate them to meet clinical regulatory requirements.

“Our daughter was just a few days old when she received a life-saving diagnosis through genomic testing.”

—Mother of Sebastiana Manuel

Read Sebastiana’s story

About Us

Rady Children’s Institute for Genomic Medicine was founded as a non-profit organization in 2014 through a transformational pledge of $120 million from Ernest and Evelyn Rady. The Institute is embedded within Rady Children’s Hospital-San Diego, the nation’s 6th largest children’s hospital. All of our work and testing is funded by philanthropy and grants.

The Institute team includes board-certified medical geneticists, bioinformaticians, software engineers, clinical laboratory scientists, genetic counselors, and physicians who channel their expertise to advance genomic pediatric medicine.

Contact Us

Rady Children's Institute for Genomic Medicine

3020 Children's Way MC5129, San Diego, CA 92123
Phone: 858-576-1700

For inquiries, use the form below. Please do not submit personal medical information.